Jupiter Topco LLC Takes $1.31 Million Position in Ingevity Corporation $NGVT

Jupiter Topco LLC purchased a new position in shares of Ingevity Corporation (NYSE:NGVT) during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 17,523 shares of the company’s stock, valued at approximately $1,309,000.

Several other hedge funds have also made changes to their positions in NGVT. BlackRock Inc. acquired a new stake in Ingevity in the second quarter worth $400,545,000. Principal Financial Group Inc. boosted its stake in Ingevity by 269.9% during the 4th quarter. Principal Financial Group Inc. now owns 652,237 shares of the company’s stock valued at $38,599,000 after purchasing an additional 475,907 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its stake in Ingevity by 311.8% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 600,380 shares of the company’s stock valued at $23,769,000 after purchasing an additional 454,579 shares during the period. Simcoe Capital Management LLC grew its position in Ingevity by 188.8% in the 2nd quarter. Simcoe Capital Management LLC now owns 624,935 shares of the company’s stock worth $26,928,000 after purchasing an additional 408,508 shares during the last quarter. Finally, Boston Partners grew its position in Ingevity by 141.6% in the 4th quarter. Boston Partners now owns 620,360 shares of the company’s stock worth $36,719,000 after purchasing an additional 363,584 shares during the last quarter. Institutional investors own 91.59% of the company’s stock.

Ingevity Trading Up 1.0%

NYSE:NGVT opened at $70.56 on Friday. The company has a market capitalization of $2.43 billion, a P/E ratio of 48.00 and a beta of 1.17. The stock’s 50 day moving average price is $73.06 and its 200 day moving average price is $71.62. The company has a debt-to-equity ratio of 22.52, a quick ratio of 1.15 and a current ratio of 1.61. Ingevity Corporation has a 52 week low of $45.85 and a 52 week high of $79.29.

Ingevity (NYSE:NGVT) last posted its earnings results on Wednesday, July 29th. The company reported $1.74 EPS for the quarter, topping the consensus estimate of $1.33 by $0.41. Ingevity had a net margin of 4.65% and a return on equity of 284.70%. The company had revenue of $314.10 million during the quarter, compared to the consensus estimate of $312.20 million. Ingevity has set its FY 2026 guidance at 5.000-5.450 EPS. On average, research analysts forecast that Ingevity Corporation will post 5.4 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of research firms have recently weighed in on NGVT. Wall Street Zen cut Ingevity from a “strong-buy” rating to a “buy” rating in a report on Saturday, August 1st. Weiss Ratings raised Ingevity from a “sell (d-)” rating to a “hold (c-)” rating in a research note on Friday, July 31st. Two equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $80.00.

Insider Buying and Selling at Ingevity

In other Ingevity news, CEO David H. Li sold 5,000 shares of the firm’s stock in a transaction dated Monday, August 17th. The stock was sold at an average price of $75.83, for a total transaction of $379,150.00. Following the transaction, the chief executive officer directly owned 120,636 shares in the company, valued at $9,147,827.88. This trade represents a 3.98% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Ryan C. Fisher sold 2,709 shares of the firm’s stock in a transaction dated Monday, August 3rd. The shares were sold at an average price of $73.72, for a total value of $199,707.48. Following the transaction, the senior vice president owned 15,722 shares in the company, valued at approximately $1,159,025.84. This trade represents a 14.70% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders sold 17,801 shares of company stock valued at $1,347,481. 0.88% of the stock is owned by company insiders.

Ingevity Company Profile

Ingevity Corporation, traded as NGVT, is a specialty chemicals and performance materials company headquartered in North Charleston, South Carolina. The company operates two primary business units: Performance Chemicals and Performance Materials. The Performance Chemicals segment produces and markets specialty chemicals derived largely from wood and other natural feedstocks, including rosin acids, tall oil fatty acids and esters, as well as specialty petroleum resins. These products serve a broad range of industries, including paper, adhesives, coatings, oilfield drilling and consumer goods.

The Performance Materials segment develops and manufactures activated carbon products and composites for applications such as automotive emissions control, industrial air and water purification, and spill containment.